These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31495543)

  • 1. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
    Lin PT; Teng W; Jeng WJ; Hsieh YC; Hung CF; Huang CH; Lui KW; Chen YC; Lin CC; Lin SM; Sheen IS; Lin CY
    J Formos Med Assoc; 2020 Feb; 119(2):635-643. PubMed ID: 31495543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Zou X; Xue M; Li J
    Med Sci Monit; 2021 Nov; 27():e934436. PubMed ID: 34840325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis.
    Su CW; Fang KC; Lee RC; Liu CA; Chen PH; Lee PC; Kao WY; Huang YH; Huo TI; Hou MC; Lin HC; Wu JC
    J Formos Med Assoc; 2020 Feb; 119(2):610-620. PubMed ID: 31542334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
    Hsu CY; Huang YH; Su CW; Lin HC; Chiang JH; Lee PC; Lee FY; Huo TI; Lee SD
    Liver Int; 2010 Jan; 30(1):77-84. PubMed ID: 19818004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization.
    Yoo SH; Jang JW; Kwon JH; Jung SM; Jang B; Choi JY
    Clin Mol Hepatol; 2016 Dec; 22(4):458-465. PubMed ID: 28081589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis.
    Han ML; Chen CC; Kuo SH; Hsu WF; Liou JM; Wu MS; Wang HP
    J Gastroenterol Hepatol; 2014 Feb; 29(2):344-51. PubMed ID: 23870023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrograde portal vein flow and transarterial chemoembolization in patients with hepatocellular carcinoma - a case-control study.
    Kirstein MM; Voigtländer T; Schweitzer N; Gebel M; Hinrichs JB; Rodt T; Manns MP; Wacker F; Potthoff A; Vogel A
    Scand J Gastroenterol; 2017 Dec; 52(12):1398-1406. PubMed ID: 28847187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Fehrenbach U; Auer TA; Gebauer B; Kloeckner R
    United European Gastroenterol J; 2022 Feb; 10(1):41-53. PubMed ID: 34918471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
    Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
    Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding.
    Lang BH; Poon RT; Fan ST; Wong J
    Am J Gastroenterol; 2004 Nov; 99(11):2158-65. PubMed ID: 15554997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
    Weng F; Li X
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):783-784. PubMed ID: 32967785
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertension.
    Elia C; Venon WD; Stradella D; Martini S; Brunello F; Marzano A; Saracco G; Rizzetto M
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):573-7. PubMed ID: 21546840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to letter to the editor: The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
    Lin PT; Teng W; Jeng WJ; Lin CY
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):785-786. PubMed ID: 32938570
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
    Kim JH; Sinn DH; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2016 Nov; 61(11):3354-3362. PubMed ID: 27435325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcome and Predictive Factors of Variceal Bleeding in Patients with Hepatocellular Carcinoma in Thailand.
    Kerdsuknirun J; Vilaichone V; Vilaichone RK
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3301-3305. PubMed ID: 30486641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience from a real-life cohort: outcome of 606 patients with hepatocellular carcinoma following transarterial chemoembolization.
    Kirstein MM; Schweitzer N; Ay N; Boeck C; Lappas K; Hinrichs JB; Voigtländer T; Wacker F; Manns MP; Rodt T; Vogel A
    Scand J Gastroenterol; 2017 Jan; 52(1):116-124. PubMed ID: 27598949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization.
    Pipa-Muñiz M; Sanmartino S; Mesa A; Álvarez-Navascués C; González-Diéguez ML; Cadahía V; Rodríguez JE; Vega F; Rodríguez M; Costilla-García SM; Varela M
    BMC Gastroenterol; 2020 Jun; 20(1):166. PubMed ID: 32487071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
    Garwood ER; Fidelman N; Hoch SE; Kerlan RK; Yao FY
    Liver Transpl; 2013 Feb; 19(2):164-73. PubMed ID: 23008091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.